A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases

Individualized genetic therapies - medicines that precisely target a genetic variant that may only be found in a small number of individuals, as few as only one - offer promise for addressing unmet needs in genetic disease, but present unique challenges for trial design. By nature these new individu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kim-McManus, Olivia (VerfasserIn) , Gleeson, Joseph G. (VerfasserIn) , Mignon, Laurence (VerfasserIn) , Smith Fine, Amena (VerfasserIn) , Yan, Winston (VerfasserIn) , Nolen, Nicole (VerfasserIn) , Demarest, Scott (VerfasserIn) , Berry-Kravis, Elizabeth (VerfasserIn) , Finkel, Richard (VerfasserIn) , Leonard, Stefanie (VerfasserIn) , Finlayson, Samuel (VerfasserIn) , Augustine, Erika (VerfasserIn) , Lyon, Gholson J. (VerfasserIn) , Schüle-Freyer, Rebecca (VerfasserIn) , Yu, Timothy (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 November 2024
In: Nature Communications
Year: 2024, Jahrgang: 15, Pages: 1-5
ISSN:2041-1723
DOI:10.1038/s41467-024-54077-5
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41467-024-54077-5
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41467-024-54077-5
Volltext
Verfasserangaben:Olivia Kim-McManus, Joseph G. Gleeson, Laurence Mignon, Amena Smith Fine, Winston Yan, Nicole Nolen, Scott Demarest, Elizabeth Berry-Kravis, Richard Finkel, Stefanie Leonard, Samuel Finlayson, Erika Augustine, Gholson J. Lyon, Rebecca Schule & Timothy Yu

MARC

LEADER 00000naa a2200000 c 4500
001 1932496068
003 DE-627
005 20250805104526.0
007 cr uuu---uuuuu
008 250805s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41467-024-54077-5  |2 doi 
035 |a (DE-627)1932496068 
035 |a (DE-599)KXP1932496068 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kim-McManus, Olivia  |e VerfasserIn  |0 (DE-588)1373174838  |0 (DE-627)193249667X  |4 aut 
245 1 2 |a A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases  |c Olivia Kim-McManus, Joseph G. Gleeson, Laurence Mignon, Amena Smith Fine, Winston Yan, Nicole Nolen, Scott Demarest, Elizabeth Berry-Kravis, Richard Finkel, Stefanie Leonard, Samuel Finlayson, Erika Augustine, Gholson J. Lyon, Rebecca Schule & Timothy Yu 
246 3 3 |a A framework for N-of-one trials of individualized gene-targeted therapies for genetic diseases 
264 1 |c 12 November 2024 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.08.2025 
520 |a Individualized genetic therapies - medicines that precisely target a genetic variant that may only be found in a small number of individuals, as few as only one - offer promise for addressing unmet needs in genetic disease, but present unique challenges for trial design. By nature these new individualized medicines require testing in individualized N-of-1 trials. Here, we provide a framework for maintaining scientific rigor in N-of-1 trials. Building upon best practices from traditional clinical trial design, recent guidance from the United States Food and Drug Administration, and our own clinical research experience, we suggest key considerations including comprehensive baseline natural history, selection of appropriate clinical outcome assessments (COAs) individualized to the patient genotype-phenotype for safety and efficacy assessment over time, and specific statistical considerations. Standardization of N-of-1 trial designs in this fashion will maximize efficient learning from this next generation of targeted individualized therapeutics. 
650 4 |a Antisense oligonucleotide therapy 
650 4 |a Clinical trials 
650 4 |a Drug discovery 
650 4 |a Gene therapy 
650 4 |a Personalized medicine 
700 1 |a Gleeson, Joseph G.  |e VerfasserIn  |4 aut 
700 1 |a Mignon, Laurence  |e VerfasserIn  |4 aut 
700 1 |a Smith Fine, Amena  |e VerfasserIn  |4 aut 
700 1 |a Yan, Winston  |e VerfasserIn  |4 aut 
700 1 |a Nolen, Nicole  |e VerfasserIn  |4 aut 
700 1 |a Demarest, Scott  |e VerfasserIn  |4 aut 
700 1 |a Berry-Kravis, Elizabeth  |e VerfasserIn  |4 aut 
700 1 |a Finkel, Richard  |e VerfasserIn  |4 aut 
700 1 |a Leonard, Stefanie  |e VerfasserIn  |4 aut 
700 1 |a Finlayson, Samuel  |e VerfasserIn  |4 aut 
700 1 |a Augustine, Erika  |e VerfasserIn  |4 aut 
700 1 |a Lyon, Gholson J.  |e VerfasserIn  |4 aut 
700 1 |a Schüle-Freyer, Rebecca  |d 1975-  |e VerfasserIn  |0 (DE-588)137544472  |0 (DE-627)695848283  |0 (DE-576)30411118X  |4 aut 
700 1 |a Yu, Timothy  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Nature Communications  |d [London] : Springer Nature, 2010  |g 15(2024), Artikel-ID 9802, Seite 1-5  |h Online-Ressource  |w (DE-627)626457688  |w (DE-600)2553671-0  |w (DE-576)331555905  |x 2041-1723  |7 nnas  |a A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases 
773 1 8 |g volume:15  |g year:2024  |g elocationid:9802  |g pages:1-5  |g extent:5  |a A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases 
856 4 0 |u https://doi.org/10.1038/s41467-024-54077-5  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41467-024-54077-5  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250805 
993 |a Article 
994 |a 2024 
998 |g 137544472  |a Schüle-Freyer, Rebecca  |m 137544472:Schüle-Freyer, Rebecca  |d 910000  |d 911100  |e 910000PS137544472  |e 911100PS137544472  |k 0/910000/  |k 1/910000/911100/  |p 14 
999 |a KXP-PPN1932496068  |e 4753201163 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Gesehen am 05.08.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"titleAlt":[{"title":"A framework for N-of-one trials of individualized gene-targeted therapies for genetic diseases"}],"name":{"displayForm":["Olivia Kim-McManus, Joseph G. Gleeson, Laurence Mignon, Amena Smith Fine, Winston Yan, Nicole Nolen, Scott Demarest, Elizabeth Berry-Kravis, Richard Finkel, Stefanie Leonard, Samuel Finlayson, Erika Augustine, Gholson J. Lyon, Rebecca Schule & Timothy Yu"]},"person":[{"given":"Olivia","display":"Kim-McManus, Olivia","family":"Kim-McManus","role":"aut"},{"display":"Gleeson, Joseph G.","given":"Joseph G.","family":"Gleeson","role":"aut"},{"given":"Laurence","display":"Mignon, Laurence","family":"Mignon","role":"aut"},{"family":"Smith Fine","role":"aut","display":"Smith Fine, Amena","given":"Amena"},{"role":"aut","family":"Yan","given":"Winston","display":"Yan, Winston"},{"role":"aut","family":"Nolen","given":"Nicole","display":"Nolen, Nicole"},{"given":"Scott","display":"Demarest, Scott","family":"Demarest","role":"aut"},{"display":"Berry-Kravis, Elizabeth","given":"Elizabeth","family":"Berry-Kravis","role":"aut"},{"given":"Richard","display":"Finkel, Richard","role":"aut","family":"Finkel"},{"display":"Leonard, Stefanie","given":"Stefanie","family":"Leonard","role":"aut"},{"role":"aut","family":"Finlayson","given":"Samuel","display":"Finlayson, Samuel"},{"given":"Erika","display":"Augustine, Erika","family":"Augustine","role":"aut"},{"role":"aut","family":"Lyon","given":"Gholson J.","display":"Lyon, Gholson J."},{"family":"Schüle-Freyer","role":"aut","given":"Rebecca","display":"Schüle-Freyer, Rebecca"},{"role":"aut","family":"Yu","display":"Yu, Timothy","given":"Timothy"}],"recId":"1932496068","title":[{"title":"A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases","title_sort":"framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases"}],"id":{"eki":["1932496068"],"doi":["10.1038/s41467-024-54077-5"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"language":["eng"],"part":{"year":"2024","volume":"15","pages":"1-5","extent":"5","text":"15(2024), Artikel-ID 9802, Seite 1-5"},"note":["Gesehen am 13.06.24"],"pubHistory":["2010-"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseasesNature Communications","recId":"626457688","title":[{"title":"Nature Communications","title_sort":"Nature Communications"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2553671-0"],"issn":["2041-1723"],"eki":["626457688"]},"origin":[{"publisherPlace":"[London] ; [London]","dateIssuedDisp":"[2010]-","publisher":"Springer Nature ; Nature Publishing Group UK"}]}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"12 November 2024"}]} 
SRT |a KIMMCMANUSFRAMEWORKF1220